Evolved By Nature - About the company
Evolved By Nature is a series C company based in Medford (United States), founded in 2013 by Gregory Altman. It operates as a Developer of bioactive peptides derived from silk protein for skincare. Evolved By Nature has raised $211M in funding from investors like Ontario Teachers' Pension Plan, The Kraft Group and Chanel. The company has 214 active competitors, including 23 funded and 19 that have exited. Its top competitors include companies like Metaphore, Tahoe Bio and Panakeia.
Company Details
Developer of bioactive peptides derived from silk protein for skincare. These peptides are clinically proven and naturally derived. The company creates ingredients designed to improve product performance and sustainability. It offers bioactive peptides and hydrogels for healthier skin. The peptides support skin restoration after damage and UV exposure.
- Website
- biotech.evolvedbynature.com/
- Phone Number
- +1 **********
- Registered Address
- Medford, Massachusetts
Key Metrics
Founded Year
2013
Location
Medford, United States
Stage
Series C
Total Funding
$211M in 3 rounds
Latest Funding Round
Investors
Ranked
7th among 214 active competitors
Employee Count
65 as on Mar 31, 2026
Legal entities associated with Evolved By Nature
Evolved By Nature is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Evolved By Nature, Inc. CIN: 462439770 , United States, Active | Dec 26, 999 | - | 86 (As on Dec 31, 2024) | - |
Sign up to download Evolved By Nature's company profile
Evolved By Nature's funding and investors
Evolved By Nature has raised a total funding of $211M over 3 rounds. Its first funding round was on Jun 11, 2019. Its latest funding round was a Series C round on Jun 30, 2022 for $*****. 8 investors participated in its latest round. Evolved By Nature has 6 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Evolved By Nature:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 30, 2022 | 5026172 | Series C | 8327237 | 8092866 | 6248349 | 9681831 |
Dec 24, 2021 | 6163555 | Series B | 3237119 | 7398560 | 5540577 | |
Jun 11, 2019 | 1438796 | Series A | 9923611 | 6314994 | 7652460 |
View details of Evolved By Nature's funding rounds and investors
Evolved By Nature's founders and board of directors
Founder? Claim ProfileThe founders of Evolved By Nature is Gregory Altman. Gregory Altman is the CEO of Evolved By Nature.
Here are the details of Evolved By Nature's key team members:
- Gregory Altman: Co-Founder & CEO of Evolved By Nature.
View details of Evolved By Nature's Founder profiles and Board Members
Evolved By Nature's employee count trend
Evolved By Nature has 65 employees as of Mar 26. Here is Evolved By Nature's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Evolved By Nature's Competitors and alternates
Top competitors of Evolved By Nature include Metaphore, Tahoe Bio and Panakeia. Here is the list of Top 10 competitors of Evolved By Nature, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Metaphore 2021, Cambridge (United States), Series C | Provider of machine language and computational platform for drug discovery | $50M | 53/100 | |
2nd | Tahoe Bio 2022, San Francisco (United States), Series B | Developer of AI models for drug design using single-cell maps. | $30M | 51/100 | |
3rd | Panakeia 2018, London (United Kingdom), Seed | Provider of AI-based software for diagnosis and precision treatment | $3.79M | 50/100 | |
4th | VantAI 2019, New York City (United States), Unfunded | Provider of a platform for computational drug designing using AI | - | - | 49/100 |
5th | PharmaTher 2020, Toronto (Canada), Public | Provider of AI-based platform for repurposing psychedelic drugs | - | - | 47/100 |
6th | Molecular Quantum Solutions 2019, Copenhagen (Denmark), Seed | Provider of computational tools for research and development | $654K | 46/100 | |
7th | Evolved By Nature 2013, Medford (United States), Series C | Developer of bioactive peptides derived from silk protein for skincare | $211M | 45/100 | |
8th | Wisecube 2016, Seattle (United States), Acquired | AI-based drug designing and development tool for researchers | - | - | 44/100 |
9th | Provider of a software solution solution for molecular modeling | $100M | 43/100 | ||
10th | Algorithmic Biologics 2021, Bengaluru (India), Seed | Provider of software solutions for molecular diagnostics and discovery | $2.84M | 43/100 |
Looking for more details on Evolved By Nature's competitors? Click here to see the top ones
Evolved By Nature's Investments and acquisitions
Evolved By Nature has made no investments or acquisitions yet.
News related to Evolved By Nature
•
Evolved By Nature Closes US 120 Series C FundingFinSMEs•Jul 01, 2022•Evolved By Nature, Ontario Teachers' Pension Plan, Senator Investment Group, The Kraft Group and 15 others
•
Chanel-backed 'activated silk' firm adds new investorsFashion Network•Jun 30, 2022•Chanel, Ontario Teachers' Pension Plan, Senator Investment Group, Mousse Investments and 3 others
•
•
•
•
Are you a Founder ?
FAQs about Evolved By Nature
Explore our recently published companies
- Sciom.com - 2003 founded, Unfunded company
- Kagulex - Horsham based, 2023 founded, Unfunded company
- Mrigangi - 2018 founded, Unfunded company
- Foxypearljewelry - Houston based, 2020 founded, Unfunded company
- ThunderBurst Media - Dallas based, 2021 founded, Unfunded company
- Ekuom - Shanghai based, Unfunded company
